Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Agios Pharmaceuticals, Inc. (AGIO) had Weighted-Average Shares Outstanding (Diluted) of 58.14M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$12.88M |
|
$-103.43M |
|
$1.68M |
|
$11.20M |
|
$129.75M |
|
$-116.87M |
|
$13.44M |
|
$-103.43M |
|
$-103.43M |
|
$-103.43M |
|
$-103.43M |
|
$-103.43M |
|
$-103.43M |
|
$-116.87M |
|
$-117.17M |
|
58.14M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
58.14M |
$-1.78 |
|
$-1.78 |
|
| Balance Sheet Financials | |
$1.03B |
|
$10.68M |
|
$352.60M |
|
$1.39B |
|
$74.76M |
|
-- |
|
$26.62M |
|
$101.38M |
|
$1.28B |
|
$1.28B |
|
$1.28B |
|
58.28M |
|
| Cash Flow Statement Financials | |
$-276.76M |
|
$287.11M |
|
$6.12M |
|
$76.25M |
|
$92.71M |
|
$16.46M |
|
$38.43M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
13.82 |
|
-- |
|
-- |
|
-- |
|
-- |
|
86.96% |
|
-907.37% |
|
-907.37% |
|
-- |
|
-803.05% |
|
-803.05% |
|
$-279.96M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
0.05 |
|
2.56 |
|
35.14 |
|
-8.05% |
|
-8.05% |
|
-7.46% |
|
-8.05% |
|
$22.04 |
|
$-4.82 |
|
$-4.76 |
|